-transparent.png){kind=logo}
It is often recommended that acetylsalicylic acid (ASA) and dipyridamole should be given together in order to obtain secondary prophylaxis against certain ischaemic diseases. Therefore, the possible pharmacokinetic interactions between these agents were assessed following single-dose exposures in 14 healthy volunteers. The plasma concentrations of ASA, salicylic acid (SA) and dipyridamole were measured by selective h.p.l.c. techniques. It was found that, while dipyridamole kinetics were unaffected by concurrent ASA, concurrent dipyridamole significantly enhanced the peak concentration (24%) and AUC (27%) of ASA. Thus, co-administered dipyridamole might influence the anti-platelet effect of ASA.
E Nitelius, and
A Melander, and
E Wåhlin-Boll
January 1989,
European journal of drug metabolism and pharmacokinetics,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
December 1997,
The Journal of clinical psychiatry,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
November 2006,
Medizinische Monatsschrift fur Pharmazeuten,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
January 1995,
European journal of clinical pharmacology,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
June 1989,
Casopis lekaru ceskych,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
September 1997,
Journal of the neurological sciences,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
September 1991,
Blutalkohol,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
January 1975,
VASA. Zeitschrift fur Gefasskrankheiten,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
August 1999,
Ugeskrift for laeger,
E Nitelius, and
A Melander, and
E Wåhlin-Boll
November 1997,
Cellular and molecular biology (Noisy-le-Grand, France),
